Patricia Dias-Gonzalez
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Kinetic profile and mucosal capsular polysaccharide IgG responses to serotype 3 pneumococcus in the adult oropharynx following an experimental human challenge.
Journal: Frontiers in microbiology
Published: March 15, 2026
High respiratory syncytial virus burden in children under 3 years of age across all care levels in England.
Journal: BMJ open respiratory research
Published: December 17, 2025
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.
Journal: Vaccine
Published: November 12, 2025
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.
Journal: The Lancet. Microbe
Published: September 05, 2024
Comprehensive review of safety in Experimental Human Pneumococcal Challenge.
Journal: PloS one
Published: November 30, 2022
Human Infection Challenge with Serotype 3 Pneumococcus.
Journal: American journal of respiratory and critical care medicine
Published: July 08, 2022
Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination.
Journal: Mucosal immunology
Published: February 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026